CUBE vs MIRM · P/E 25, rev $1.07B vs rev $336.9M
CubeSmart (CUBE) versus Mirum Pharmaceuticals Inc (MIRM) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported MIRM revenue for 2024-12-31 was $336.9M. Net income was -$87.9M. Revenue was up 80.8% from 2023-12-31 to 2024-12-31. MIRM currently screens at market cap $6.22B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. MIRM currently screens at market cap $6.22B.
Not investment advice. Open the CUBE and MIRM stock pages for the full models.
Not investment advice.